Improving the global management of the neurogenic bladder patient: part I. The complexity of patients

Authors: Denys, Pierre¹; Corcos, Jacques²; Everaert, Karel³; Chartier-Kastler, Emmanuel⁴; Fowler, Clare⁵; Kalsi, Vinay⁵; Nitti, Victor⁶; Schulte-Baukloh, Heinrich⁷; Schurch, Brigitte⁸

Source: Current Medical Research and Opinion, Volume 22, Number 2, February 2006 , pp. 359-365(7)

Publisher: Informa Healthcare

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Abstract:

Background: The management of urinary incontinence in patients with neurological disease is complex. Physicians face a multitude of challenges related to progression of the primary condition, the presence of a diversity of other related and unrelated symptoms, the safety, efficacy and tolerability issues associated with multiple therapies being required and the changing need for collaboration with other specialities.

Scope: Current guidelines produced by the urological communities, as well as the disease-focused organizations, aim to standardize care in their specific group of patients. A passive approach to implementation, however, means that guidelines produced are all too frequently not readily available to, read by or followed by the wider audience. In addition, each speciality has its own guidelines and a different view of the primary focus of care in neurological patients, which may lead to variations in recommendations and, subsequently, in clinical practice. A review of current urological and disease specific guidelines was made to evaluate differences between the published guidance between the specialities and within urology itself.

Conclusions: Although availability of effective therapies remains a cornerstone of neurogenic bladder treatment, consideration must also be given to the non-pharmacological and surgical issues related to the global management of this population. Improved cross-speciality interactions and development of patient-specific treatment and follow-up plans, which are in keeping with the current guidelines of each speciality involved, may serve to enhance physicians' understanding of the importance of effective urinary incontinence treatment as well as the overall management of the patient.

Keywords: BOTULINUM TOXIN; GLOBAL PATIENT MANAGEMENT; MULTIDISCIPLINARY; NEUROGENIC URINARY INCONTINENCE; NEUROLOGICAL DISEASE

Document Type: Commentary

DOI: 10.1185/030079906X89702

Affiliations: 1: Affiliation Hôpital Raymond Poincaré, Garches, France 2: Department of Urology, Jewish General Hospital, Montreal, Quebec, Canada 3: Dienst Urologie, Ghent University Hospital, Ghent, Belgium 4: Urology Department, Groupe Hospitalier Pitié-Salpétrière, 83 Boulevard de l'Hôpital, 75013 Paris, France 5: Institute of Neurology-UCL, National Hospital for Neurology and Neurosurgery, London, UK 6: Department of Urology, New York University, New York, NY, USA 7: Department of Urology, St Hedwig Hospital, Berlin, Germany 8: Spinal Cord Injury Centre, University Hospital Balgrist, Zurich, Switzerland

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$51.50 plus tax Refund Policy

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.